THIS PAGE HAS BEEN ARCHIVED AND IS NO LONGER UPDATED.
We apologize for the inconvenience.
To find similar material or the current version of the page, please visit one the following resources:
Health Topics || Country Sites || News Releases || Our New Homepage


ESTA PÁGINA HA SIDO ARCHIVADA Y YA NO ES ACTUALIZADA.
Pedimos disculpas por la molestia.
Para encontrar material similar o una versión actualizada de la página, visite uno de los siguientes recursos:
Temas de salud || Sitios de países || Comunicados de prensa || Nuestra nueva página de inicio


Technical guidelines for access and rational use of antiviral drugs and vaccines for influenza A (H1N1) pandemic

PAHO applies the following technical guidelines to help Member States ensure access to and rational use of antiviral drugs in the case of an influenza A (H1N1) pandemic. A complete list of PAHO guidelines and recommendations is available at:

icon Extension of shelf of Tamiflu (oseltamivir phosphate)- Roche (29.08 kB)

icon Questions and Answers on the availability treatment (18.03 kB)

icon PAHO/WHO recommendations to guide planning of needs and management of antiviral drug inventories (Oseltamivir) (73.96 kB)

pdf  Provisional recommendations for management of confirmed or probable patients infected by the influenza A (H1N1) virus and close contacts with antiviral treatment. Version April 30, 2009 (32.28 kB)

* All these documents are available in Spanish only